Punch2027: Atiku can’t win 25m northern votes when son backs Tinubu – APC chieftainInquirerVideos of Santiago, Corona, ex-Pres. Duterte played in impeachment trialThe Jerusalem PostPro-Palestinian protesters demand Yoav Gallant's arrest during New York City visitBollywood HungamaAyushmann Khurrana and Tiger Shroff seek security cover amid threats; Mumbai Police considers X-category protectionInquirer EntertainmentWATCH: BTS members explore Taiwan night market ahead of ‘Arirang’ concertStraits Times SportMontoya returns as Argentina make seven changes for France clashZDF heuteEntdecken Sie das ZDF-NachrichtenstudioCNN بالعربيةمحاكاة كونية غير مسبوقة ترصد أول ملياري سنة من نشأة الكونRTL BoulevardUnieke uitspraak Internationaal Gerechtshof: Myanmar schuldig aan genocide op RohingyaBBC BusinessIndian driver wins $1.3m in life-changing lottery prizeScreen RantTerry Pratchett's Discworld: Adventures in Lancre and Überwald Officially Releasing October 2027TVN24Ważna informacja dla użytkowników systemu ePUAP. "Przepraszamy"
The Daily Newsstand · Free, Always
Thursday, November 19, 2026

Evotec, Bristol Myers advance protein pact with 2nd IND nod; EVO shares rise

Translate
Close-Up of Labor Assistant taking Medical Vials in Clinic

alexey_ds/E+ via Getty Images

  • Evotec SE (EVO) Thursday said that its strategic protein degradation partnership with Bristol Myers Squibb (BMY) has received a second Investigational New Drug acceptance from the U.S. Food and Drug Administration (FDA).
  • The first candidate produced under the partnership
View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.